Related Experiment Video
Updated: Nov 20, 2025
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
780
Thyroid angiosarcoma (TAS) - A rare diagnosis not to be missed
Dimitrios Kehagias1, Eirini Kostopoulou2, Panagiota Ravazoula3
1Department of General Surgery University Hospital of Patras Rio Greece.
Clinical Case Reports
|January 25, 2021
Summary
Primary اتمنى (TAS), a rare and aggressive tumor, requires increased awareness for timely diagnosis and treatment. Understanding the disease course and outcomes can optimize therapeutic strategies and improve patient survival.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Primary اتمنى (TAS) is a rare and aggressive mesenchymal tumor.
- Early diagnosis and prompt treatment are crucial for managing TAS.
- Limited knowledge exists regarding the long-term prognosis and optimal management of TAS.
Observation:
- Awareness of primary TAS is essential for prompt diagnosis.
- Radical surgery and adjuvant radiation are key components of treatment.
- Further understanding of disease progression is needed.
Findings:
- Increased awareness facilitates early detection and intervention.
- Timely surgical resection and radiation therapy are critical.
- Knowledge of TAS outcomes can guide treatment decisions.
Implications:
- Enhanced awareness can lead to improved diagnostic rates for primary TAS.
- Optimizing surgical and radiation protocols may improve patient survival.
- Further research into TAS natural history is warranted to refine treatment strategies.
